Clearside Biomedical has filed a registration statement with the U.S. Securities and Exchange Commission concerning a proposed initial public offering of shares of common stock, the company announced in a press release.The number of shares to be offere…
INDIANAPOLIS–(BUSINESS WIRE)–Renaissance, a leading ancillary insurance carrier of customizable dental and vision plans, is expanding its Florida office with the addition of dental-industry veteran Cynthia Byndas.
OCT jumped into our lives in 1991 when Huang and colleagues published about a “noninvasive cross-sectional imaging technology in biological systems.” Since then, major advancements have been made. Spectral-domain and swept-source OCT platforms brought faster scans and higher resolution. Also, OCT technology has been proposed in conjunction with adaptive optics, which may allow further resolution, up to a single photoreceptor cell. Polarized light combined with high-resolution OCT scanning may improve characterization of the retinal pigment epithelium. No doubt, therefore, that with the introduction of OCT, assessment of fundus structure has (Read more...)
Over the past 20 years, OCT has developed rapidly as a noninvasive method of retinal imaging. OCT angiography, or OCTA, is the latest evolution of this technology, allowing extreme close-up imaging of the retinal vasculature for assessing retinal vascular diseases, and holds potential for guiding treatment decisions and monitoring patient responses to therapy.“The huge progress consists in having both functional and morphological assessment from a single dye-less examination. The rapid and noninvasive nature of the OCTA allows an easier follow-up of morphological and functional changes in prolonged, repetitive and even (Read more...)
A new study shows that explaining their blindness to others is the biggest difficulty faced by people with Retinitis Pigmentosa (RP), which results in tunnel vision.
(MedPage Today) — Smooth sailing for FDA nominee